Hospitalization

A single dose of pegylated interferon lambda used as early treatment in patients with COVID-19 was effective in lowering the total occurrences of hospitalization and ED visits, a study published in The New England Journal of Medicine found.

Quality of care for patients with acute exacerbations of COPD did not improve after the Hospital Readmissions Reduction Program was put in place compared with the period prior to the program’s implementation, according to study results.

IL-6 receptor antagonists and antiplatelet agents improved chances for 6-month survival among patients with COVID-19, according to study results presented at Society of Critical Care Medicine’s Critical Care Congress and published in JAMA.

Primary care physicians who used a community health information exchange significantly improved their patients’ transition from hospitalization to outpatient care, according to findings published in Annals of Family Medicine.

Another study has demonstrated that a shorter course of antibiotics may be better, this time for the treatment of complicated UTIs when antibiotics with comparable IV and oral bioavailability are administered.

Children aged 1 to 4 years with acute hypoxemic respiratory failure did not experience shorter hospital stays on early high-flow oxygen compared with standard oxygen therapy, according to study results.

Patients with giant cell arteritis may require unexpected and sudden care, with as many as one-third requiring readmission to a health care center within 6 months of an episode, according to data published in Arthritis Care & Research.

The CDC for the first time has estimated how effective the bivalent COVID-19 vaccines have been against the newest dominant omicron subvariant of SARS-CoV-2.

The needs of families are largely unmet when a parent is hospitalized for a mental illness, with the need for a broad range of care models required to address these gaps, according to a study published in BMC Psychiatry.

Sarcopenia significantly increases risk for adverse outcomes in adults with HF with reduced ejection fraction, including death and rehospitalization, as well as risk for falls and hospitalization, researchers reported.